Phase I trial of weekly docetaxel with a 4-weekly cisplatin administration in patients with advanced gastric carcinomaPOLYZOS, Aristides; SYRIGOS, Konstantinos; STERGIOU, John et al.Cancer chemotherapy and pharmacology. 2005, Vol 55, Num 5, pp 466-470, issn 0344-5704, 5 p.Article

A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and oxaliplatin in patients with advanced solid tumorsKALBAKIS, Kostas; PAPPAS, Periklis; KOUROUSSIS, Charalambos et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 3, pp 449-456, issn 0344-5704, 8 p.Article

Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer : A randomized, multicenter phase III trialGEORGOULIAS, Vassilis; ANDROULAKIS, Nikolaos; CHANDRINOS, Vassilis et al.Lung cancer. 2008, Vol 59, Num 1, pp 57-63, issn 0169-5002, 7 p.Article

A dose escalation study of the biweekly administration of paclitaxel, oxaliplatin and capecitabine in patients with advanced solid tumorsSARIDAKI, Zacharenia; BOZIONELOU, Vasiliki; MAVROUDIS, Dimitris et al.Oncology. 2007, Vol 72, Num 1-2, pp 45-50, issn 0030-2414, 6 p.Article

Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer : a multicentre phase II studyARDAVANIS, Alexandros; MAVROUDIS, Dimitris; GEORGOULIAS, Vassilis et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 6, pp 742-748, issn 0344-5704, 7 p.Article

Pemetrexed Versus Erlotinib in Pretreated Patients With Advanced Non-Small Cell Lung Cancer: A Hellenic Oncology Research Group (HORG) Randomized Phase 3 StudyKARAMPEAZIS, Athanasios; VOUTSINA, Alexandra; AGELAKI, Sofia et al.Cancer. 2013, Vol 119, Num 15, pp 2754-2764, issn 0008-543X, 11 p.Article

FEC versus sequential docetaxel followed by epirubicin/ cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG)POLYZOS, Aristides; MALAMOS, Nikolaos; KARVOUNIS, Nikolaos et al.Breast cancer research and treatment. 2010, Vol 119, Num 1, pp 95-104, issn 0167-6806, 10 p.Article

A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancerSARIDAKI, Zacharenia; MALAMOS, Nikolaos; KOURAKOS, Panagiotis et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 1, pp 35-42, issn 0344-5704, 8 p.Article

A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancerKOTSAKIS, Athanasios; AGELAKI, Sophia; GEORGOULIAS, Vassilis et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 2, pp 415-422, issn 0344-5704, 8 p.Article

A Retrospective Analysis of Non-platinum-based First- and Second-line Chemotherapy in Patients with Advanced Non-small Cell Lung CancerKOTSAKIS, Athanasios; HATZIDAKI, Dora; AGELAKI, Sophia et al.Anticancer research. 2010, Vol 30, Num 10, pp 4335-4342, issn 0250-7005, 8 p.Article

Second-line chemotherapy with Capecitabine (Xeloda) and Docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trialKATOPODIS, Ourania; POLYZOS, Aris; KENTEPOZIDIS, Nikolaos et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 2, pp 361-368, issn 0344-5704, 8 p.Article

A phase I trial of gemcitabine, docetaxel and carboplatin administered every 2 weeks as first line treatment in patients with advanced breast cancerBOZIONELOU, Vasiliki; KALBAKIS, Kostas; VAMVAKAS, Lambros et al.Cancer chemotherapy and pharmacology. 2009, Vol 64, Num 4, pp 785-791, issn 0344-5704, 7 p.Article

Gefitinib in Combination with Gemcitabine and Vinorelbine in Patients with Metastatic Breast Cancer Pre-treated with Taxane and Anthracycline Chemotherapy : A Phase I/II TrialGIOULBASANIS, Ioannis; SARIDAKI, Zacharenia; KALYKAKI, Antonia et al.Anticancer research. 2008, Vol 28, Num 5B, pp 3019-3025, issn 0250-7005, 7 p.Article

Gemcitabine plus oxaliplatin combination (GEMOX regimen) in pretreated patients with advanced non-small cell lung cancer (NSCLC) : A multicenter phase II studyKAKOLYRIS, Stylianos; ZIRAS, Nikolaos; VAMVAKAS, Lambros et al.Lung cancer. 2006, Vol 54, Num 3, pp 347-352, issn 0169-5002, 6 p.Article

A dose escalation study of leucovorin (LV) and 48-hour continuous infusion of 5-fluorouracil in combination with cyclophosphamide and vinorelbine in pretreated patients with metastatic breast cancerKOUROUSSIS, Charalambos; KALBAKIS, Konstantinos; ANDROULAKIS, Nikolaos et al.Anticancer research. 2004, Vol 24, Num 6, pp 4217-4221, issn 0250-7005, 5 p.Article

Continuous Administration of Daily Low-Dose Temozolomide in Pretreated Patients with Advanced Non-Small Cell Lung Cancer : A Phase II StudyKOUROUSSIS, Charalambos; VAMVAKAS, Lambros; VARDAKIS, Nikolaos et al.Oncology. 2009, Vol 76, Num 2, pp 112-117, issn 0030-2414, 6 p.Article

A multicenter phase II study of the combination of gemcitabine and docetaxel in previously treated patients with small cell lung cancerAGELAKI, Sofia; VESLEMES, Marinos; VAMVAKAS, Lambros et al.Lung cancer. 2004, Vol 43, Num 3, pp 329-333, issn 0169-5002, 5 p.Article

A multicenter phase I trial of metronomic oral vinorelbine plus cisplatin in patients with NSCLCPALLIS, Athanasios G; CHANDRINOS, Vassilis; PAVLAKOU, Georgia et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 6, pp 1239-1245, issn 0344-5704, 7 p.Article

Phase III Study Comparing Sequential Versus Alternate Administration of Cisplatin-Etoposide and Topotecan as First-line Treatment in Small Cell Lung CancerBAKA, Sophia; AGELAKI, Sophia; ANDROULAKIS, Nikolaos et al.Anticancer research. 2010, Vol 30, Num 7, pp 3031-3038, issn 0250-7005, 8 p.Article

A multicenter phase II study of sequential vinorelbine and cisplatin followed by docetaxel and gemcitabine in patients with advanced non-small cell lung cancerPALLIS, Athanasios G; AGELIDOU, Athina; KENTEPOZIDIS, Nikolaos et al.Lung cancer. 2006, Vol 52, Num 2, pp 165-171, issn 0169-5002, 7 p.Article

A multicenter phase II study of docetaxel in combination with gefitinib in gemcitabine-pretreated patients with advanced/metastatic pancreatic cancerIGNATIADIS, Michail; POLYZOS, Aris; STATHOPOULOS, George P et al.Oncology. 2006, Vol 71, Num 3-4, pp 159-163, issn 0030-2414, 5 p.Article

Gemcitabine plus Oxaliplatin (GEMOX) in Pretreated Patients with Advanced Ovarian Cancer : A Multicenter Phase II Study of the Hellenic Oncology Research Group (HORG)KALYKAU, Antonia; PAPAKOTOULAS, Pavlos; MAVROUDIS, Dimitris et al.Anticancer research. 2008, Vol 28, Num 1B, pp 495-500, issn 0250-7005, 6 p.Article

Oxaliplatin as first-line treatment in inoperable biliary tract carcinoma : A multicenter phase II studyANDROULAKIS, Nikolaos; ARAVANTINOS, Gerasimos; GEORGOULIAS, Vassilis et al.Oncology. 2006, Vol 70, Num 4, pp 280-284, issn 0030-2414, 5 p.Article